RXST vs. NTNX
RXST (RxSight, Inc.) and NTNX (Nutanix, Inc.) are both stocks. RXST operates in Medical Devices (Healthcare), while NTNX operates in Software - Infrastructure (Technology). Over the past 3 years, RXST returned -42.45%/yr vs 19.42%/yr for NTNX. At a 0.22 correlation, their price movements are largely independent.
Performance
RXST vs. NTNX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RXST achieves a -52.40% return, which is significantly lower than NTNX's -9.83% return.
RXST
- 1D
- 4.86%
- 1M
- -18.49%
- YTD
- -52.40%
- 6M
- -59.44%
- 1Y
- -63.56%
- 3Y*
- -42.45%
- 5Y*
- —
- 10Y*
- —
NTNX
- 1D
- -0.62%
- 1M
- -1.08%
- YTD
- -9.83%
- 6M
- -11.96%
- 1Y
- -35.94%
- 3Y*
- 19.42%
- 5Y*
- 3.56%
- 10Y*
- —
RXST vs. NTNX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
RXST RxSight, Inc. | -52.40% | -69.69% | -14.73% | 218.23% | 12.62% | -35.71% |
NTNX Nutanix, Inc. | -9.83% | -15.51% | 28.29% | 83.07% | -18.24% | -12.54% |
Correlation
The correlation between RXST and NTNX is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Jul 30, 2021 | 0.22 |
The correlation between RXST and NTNX shifts across timeframes, from 0.09 (1 year) to 0.22 (all time), reflecting how their relationship changes across market environments.
Fundamentals
RXST:
$204.88M
NTNX:
$13.61B
RXST:
-$1.14
NTNX:
$0.93
RXST:
1.60
NTNX:
5.00
RXST:
$127.48M
NTNX:
$2.75B
RXST:
$98.18M
NTNX:
$2.39B
RXST:
-$50.09M
NTNX:
$293.53M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RXST vs. NTNX — Risk / Return Rank
RXST
NTNX
RXST vs. NTNX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for RxSight, Inc. (RXST) and Nutanix, Inc. (NTNX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RXST | NTNX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.08 | ||
| Sortino ratioReturn per unit of downside risk | -0.28 | ||
| Omega ratioGain probability vs. loss probability | 0.84 | 0.88 | -0.04 |
| Calmar ratioReturn relative to maximum drawdown | -0.96 | -0.63 | -0.33 |
| Martin ratioReturn relative to average drawdown | -1.56 | -1.03 | -0.53 |
Loading charts...
Drawdowns
RXST vs. NTNX - Drawdown Comparison
The maximum RXST drawdown since its inception was -92.86%, which is greater than NTNX's maximum drawdown of -80.40%. Use the drawdown chart below to compare losses from any high point for RXST and NTNX.
Loading charts...
Drawdown Indicators
| RXST | NTNX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.86% | -80.40% | -12.46% |
Max Drawdown (1Y)Largest decline over 1 year | -66.50% | -57.58% | -8.92% |
Max Drawdown (3Y)Largest decline over 3 years | -92.86% | -58.58% | -34.28% |
Max Drawdown (5Y)Largest decline over 5 years | — | -68.71% | — |
Current DrawdownCurrent decline from peak | -92.28% | -43.89% | -48.39% |
Average DrawdownAverage peak-to-trough decline | -37.40% | -40.57% | +3.17% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 40.72% | 35.02% | +5.70% |
Volatility
RXST vs. NTNX - Volatility Comparison
RxSight, Inc. (RXST) has a higher volatility of 16.87% compared to Nutanix, Inc. (NTNX) at 15.40%. This indicates that RXST's price experiences larger fluctuations and is considered to be riskier than NTNX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RXST | NTNX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.87% | 15.40% | +1.47% |
Volatility (6M)Calculated over the trailing 6-month period | 45.04% | 35.96% | +9.08% |
Volatility (1Y)Calculated over the trailing 1-year period | 74.26% | 46.35% | +27.91% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 69.09% | 49.59% | +19.50% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 69.09% | 58.47% | +10.62% |
Dividends
RXST vs. NTNX - Dividend Comparison
Neither RXST nor NTNX has paid dividends to shareholders.
Financials
RXST vs. NTNX - Financials Comparison
This section allows you to compare key financial metrics between RxSight, Inc. and Nutanix, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
RXST vs. NTNX - Profitability Comparison
RXST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, RxSight, Inc. reported a gross profit of 23.50M and revenue of 30.89M. Therefore, the gross margin over that period was 76.1%.
NTNX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Nutanix, Inc. reported a gross profit of 610.68M and revenue of 703.07M. Therefore, the gross margin over that period was 86.9%.
RXST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, RxSight, Inc. reported an operating income of -17.83M and revenue of 30.89M, resulting in an operating margin of -57.7%.
NTNX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Nutanix, Inc. reported an operating income of 68.56M and revenue of 703.07M, resulting in an operating margin of 9.8%.
RXST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, RxSight, Inc. reported a net income of -15.88M and revenue of 30.89M, resulting in a net margin of -51.4%.
NTNX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Nutanix, Inc. reported a net income of 72.09M and revenue of 703.07M, resulting in a net margin of 10.3%.
Frequently Asked Questions
RXST and NTNX have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RXST has higher volatility (16.87%) compared to NTNX (15.40%). In terms of maximum drawdown, RXST dropped -92.86% vs NTNX's -80.40%.
NTNX currently has the higher Sharpe Ratio (-0.78 vs -0.86), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RXST and NTNX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer